May 20, 2013

Weather

Overcast

74°
Conditions at North Texas Regional Airport, TX
Save Email Print Bookmark and Share
A A
Reporter: KXII-TV Staff Email

H1N1 arrives in Grayson County

GRAYSON COUNTY, Tex. -- The H1N1 influenza has arrived in Grayson County. Health officials announced this afternoon there are now two confirmed H1N1 cases in Grayson County.

According to the Grayson County Health Department and Grayson County Emergency Management, both people infected with the virus have already made full recoveries. One of the infected persons was identified only as a woman in Grayson County. The other is a student in the Pottsboro Independent School District.

Public health officials say it was only a matter of time before H1N1 appeared in Grayson County and that there is no cause for alarm

"We believe that this is a success story, that while this confirmation is just coming to our attention, there has not been a widespread transmission of this disease in our community," said Sarah Somers, Grayson County Emergency Management coordinator.

Health officials credit the public for the low transmission rate, saying that people washing their hands and staying home when ill has helped keep the flu from spreading.


Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus

WebMD Health News

AP Top Health Stories

  • Measles surges in UK years after vaccine scare

    In this photo Thursday, April 25, 2013 Lucy Butler,15, getting ready to have her measles jab at All Saints School in Ingleby Barwick, Teesside, England, as a national vaccination catch-up campaign has been launched to curb a rise in measles cases in England. More than a decade ago, British parents refused to give measles shots to at least a million children because of a vaccine scare that raised the specter of autism. Now, health officials are scrambling to catch up and stop a growing epidemic of the contagious disease. (AP Photo/Owen Humphreys, PA) UNITED KINGDOM OUT - NO SALES - NO ARCHIVESLONDON (AP) — More than a decade ago, British parents refused to give measles shots to at least a million children because of a vaccine scare that raised the specter of autism. Now, health officials are scrambling to catch up and stop a growing epidemic of the contagious disease.


  • WHO says single yellow fever shot is enough
    GENEVA (AP) — The World Health Organization says a yellow fever booster vaccination given 10 years after the initial shot isn't necessary.
  • Tiny preemies get a boost from live music therapy

    Music therapist Elizabeth Klinger, right, quietly plays guitar and sings for Augustin as he grips the hand of his mother, Lucy Morales, in the newborn intensive care unit at Ann & Robert H. Lurie Children's Hospital in Chicago on Monday, May 6, 2013. Research suggests that music may help those born way too soon adapt to life outside the womb. Recent studies and anecdotal reports suggest the vibrations and soothing rhythms of music, especially performed live in the hospital, might benefit preemies and other sick babies. (AP Photo/M. Spencer Green)CHICAGO (AP) — As the guitarist strums and softly sings a lullaby in Spanish, tiny Augustin Morales stops squirming in his hospital crib and closes his eyes.


  • Actavis to buy Warner Chilcott in $8.5 billion stock deal
    (Reuters) - Generic drugmaker Actavis Inc, which has been the subject of intense takeover speculation, said on Monday that it had struck a deal to buy specialty pharmaceuticals company Warner Chilcott Plc for $8.5 billion in stock. The move comes as Actavis has spurned approaches from Canadian pharmaceutical company Valeant Pharmaceuticals International Inc and Mylan Inc. Analysts have said that if Actavis were to buy Warner Chilcott, it would kill the chances of its being taken over. Warner Chilcott shareholders will receive 0.16 share of the combined company. ...
  • XenoPort to drop multiple sclerosis drug after trial failure
    (Reuters) - XenoPort Inc said it will stop developing its experimental multiple sclerosis treatment after data from a late-stage trial showed the drug did not improve patients' condition significantly compared with a placebo. The company said it will shut down all activities related to the drug, arbaclofen placarbil, and planned to provide an update on the impact of the expected savings. The drug did not show statistical significance compared to the placebo on two clinical scales - severity of symptoms and response to treatment, and spasticity. ...